(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 12.86%-50.5K | 31.28%-55.01K | -183.07%-54.74K | 111.13%49.74K | 352.32%207.08K | 2.05%-57.95K | 66.11%-80.04K | 72.19%-19.34K | -160.62%-446.94K | -469.43%-82.07K |
Net income from continuing operations | 4.11%-57.03K | -59.93%-99.81K | -21.53%-72.75K | 91.09%-25.39K | 268.78%156.35K | 13.12%-59.47K | 4.13%-62.41K | -1.96%-59.86K | -105.32%-284.9K | 68.37%-92.64K |
Asset impairment expenditure | ---- | ---- | ---- | --35K | ---- | ---- | ---- | ---- | --0 | ---- |
Remuneration paid in stock | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Change In working capital | 328.98%6.53K | -20.67%-21.28K | -55.56%18.01K | 124.77%40.13K | 48.79%15.73K | -83.61%1.52K | 89.69%-17.64K | 474.03%40.52K | -231.63%-162.04K | -90.97%10.57K |
-Change in receivables | 203.54%2.91K | 7.15%-883 | -95.48%1.72K | 234.01%34.32K | -19.52%-3.72K | 136.31%960 | 93.71%-951 | 905.02%38.04K | -308.80%-25.61K | -7.79%-3.12K |
-Change in prepaid assets | -400.36%-1.69K | 122.23%375 | 217.67%9.15K | 113.76%2.32K | 132.92%563 | -95.29%562 | 93.77%-1.69K | --2.88K | ---16.84K | ---1.71K |
-Change in payables and accrued expense | --5.3K | -38.50%-20.78K | 1,907.09%7.14K | 102.92%3.49K | 22.68%18.89K | --0 | 88.36%-15K | 93.53%-395 | -207.90%-119.59K | -87.17%15.4K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 12.86%-50.5K | 31.28%-55.01K | -183.07%-54.74K | 111.13%49.74K | 352.32%207.08K | 2.05%-57.95K | 66.11%-80.04K | 72.19%-19.34K | -160.62%-446.94K | -469.43%-82.07K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 547.55%89.9K | -431.89%-4.29K | 0.00%-2.5K | 50.67%-23.47K | -75 | -452.14%-20.09K | -129.71%-806 | 94.63%-2.5K | -120.15%-47.58K | 0 |
Capital expenditure reported | ---- | ---- | 0.00%-2.5K | 50.67%-23.47K | ---- | ---- | ---- | 94.63%-2.5K | 77.37%-47.58K | --0 |
Net other investing changes | 49.72%-10.1K | ---- | ---- | ---- | ---- | ---20.09K | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 547.55%89.9K | -431.89%-4.29K | 0.00%-2.5K | 50.67%-23.47K | ---75 | -452.14%-20.09K | -129.71%-806 | 94.63%-2.5K | -120.15%-47.58K | --0 |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 0 | 0 | 250K | 0 | 0 | 0 | ||||
Net common stock issuance | --0 | --0 | --250K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | --0 | --0 | --250K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
Net cash flow | ||||||||||
Beginning cash position | 184.57%404.61K | 108.00%463.9K | 10.73%271.15K | -66.88%244.88K | -80.38%64.15K | -63.52%142.18K | -64.21%223.03K | -66.88%244.88K | 9.57%739.39K | -60.03%326.94K |
Current changes in cash | 150.49%39.4K | 26.66%-59.29K | 982.54%192.76K | 105.31%26.27K | 352.23%207K | -24.26%-78.04K | 65.37%-80.85K | 81.20%-21.84K | -865.59%-494.52K | -4.50%-82.07K |
End cash Position | 592.20%444.01K | 184.57%404.61K | 108.00%463.9K | 10.73%271.15K | 10.73%271.15K | -80.38%64.15K | -63.52%142.18K | -64.21%223.03K | -66.88%244.88K | -66.88%244.88K |
Free cash from | 12.86%-50.5K | 32.29%-52.5K | -162.09%-57.24K | 105.31%26.27K | 323.73%183.61K | 7.73%-57.95K | 66.78%-77.54K | 81.20%-21.84K | -29.56%-494.52K | -4.50%-82.07K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data